The ERS Tobacco Control Committee finds lack of evidence supporting the tobacco industry's “harm reduction” claims. All nicotine products remain harmful and addictive. It is vital to reduce tobacco use and protect youth from addiction to novel products. bit.ly/3Ovm98C

Today RE-SAMPLE released the 9th edition of its #newsletter! Read it here ➡ mailchi.mp/7baa07fe1962/r… We present you another member of our #consortium, some news & the amazing work of our partners on #publications with 4 new #articles since our last newsletter! #ehealth

RE-SAMPLE released the 9th edition of its #newsletter! Read it here ➡ mailchi.mp/7baa07fe1962/r… We present you another member of our #consortium, some news & the amazing work of our partners on #publications with 4 new #articles since our last newsletter! #ehealth #rwd

RE-SAMPLE platform employs HL7 International standard & SNOMED International terminology to enhance the utilisation of #healthdata in #MachineLearning . This commitment to #Interoperability is a cornerstone of RE-SAMPLE, unlocking new dimensions in #data analysis for improved #patient outcomes

📖 Order the ERS Monograph on COPD in the 21st Century now! This new Monograph provides an up-to-date overview of what is happening in this exciting field, both at a basic and a clinical level. Get your copy on the ERS bookshop: bit.ly/49XzgHL

One week to go until the ERS Lung Science Conference 2024 gets underway. There is still time to register for this year’s event, with limited spaces remaining onsite and online attendance available. Book your place here: bit.ly/4bCSUdJ #LSC2024

Join the European Research & Innovation Days 2024 on 20 & 21 March! 🚀 Celebrate R&I achievements, discover #EUfunded projects & find out the latest about #HorizonEU. Stay tuned 👇 europa.eu/!rBvt7D #RIDaysEU

ERJOR: Real-world walking cadence should be further considered as a prognostic marker of COPD in observational research and in drug and non-drug clinical trials, as well as while developing pulmonary rehabilitation and physical activity interventions bit.ly/3TfJezh

ERJ Open Research: In smokers aged 40–49 years, centrilobular emphysema and the airway/lung size ratio on CT were independently associated with low respiratory function, one of the key factors leading to the future development of COPD bit.ly/4b6Blm5

The ERS Lung Science Conference 2024 gets underway from tomorrow in Estoril, Portugal! 📱 Join the conversation on social media using #LSC2024. If you’re unable to join us onsite, you can still register for online attendance – register here: bit.ly/4bCSUdJ

Potential mechanisms driving the increased risk of cardiovascular comorbidities in patients with COPD reader.ersjournals.com/copd-in-the-21… ERS publications

RE-SAMPLE supports patient-centeredness & encourage individuals to take an active role in their health through Shared Decision Making (SDM) Healthentia clinical platform enables clinicians & patients to set achievable goals, track progress & conduct follow-up appointments

💡 The 22nd ERS Lung Science Conference is officially underway! ERS Conference & Seminars Director Prof. Silke Meiners officially opened #LSC2024 a short time ago, with Prof. Alvar Agusti hosting the opening lecture. Up next - poster session 1 & networking! ERS Early-Career Members

Last week a new article was published under RE-SAMPLE titled “Technology-supported shared decision-making in chronic conditions: A systematic review of randomized controlled trials”! Want to read more about it? Check out the open access paper: sciencedirect.com/science/articl…

Let’s go! Today, RE-SAMPLE partners are meeting in Bremen thanks to DFKI for 3 days of work!

2nd day of #work for our consortium meeting! Discussions and cooperation are intense and insightful on the RE-SAMPLE solution! A lot of thanks to DFKI for hosting us! #resarch #cooperation #horizon2020 #copd

Yesterday, WARIFA Project & RE-SAMPLE met to discuss #synergies & collaboration! WARIFA works to develop a prototype of a combined early #riskassessment tool that will provide individual citizens with #personalized #recommendations for the management of #chronicconditions

In RE-SAMPLE, we're validating #machinelearning models using data from 3 hospitals to power our Virtual Companionship Programme Our approach: re-sampling, cross-validation, permutation testing & interpretability for transparency. Ensuring fairness, accuracy & reliable care!

Our new RE-SAMPLE #newsletter is out! 🥳 Want to know more about our last activities? Interested about the #gdpr or continuous #enduser involvement? You can read about this and a lot more in our last edition! ➡️mailchi.mp/373bf5c6aa47/r… #research #horizon2020 #copd #ehealth

The paper from colleagues at Roessingh R&D (inactive) is accepted as case study for #NordiCHI2024 under RE-SAMPLE . They investigated the attitudes of people with #copd towards health monitoring, risk predictions and #virtualcoaching. We hope to see you in Uppsala at their presentation!